PLAUR and cancer: All soluble uPAR forms were found to be significantly higher in cancer patients than in patients presenting with ONM findings; uPAR(I) P=0.0006, suPAR(I–III) P<0.0001 and suPAR(I–III)+(II–III) P<0.0001.